JPRN-UMIN000013807已完成未知
ong-term Effect of Tolvaptan Administration for Outcome and Neurohormonal Factors in Patients with Heart Failure - Clinical Effect of Long-term Tolvaptan Administration
ihon University Surugadai Hospital0 个研究点目标入组 100 人开始时间: 2014年4月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with a history of hypersensitivity for tolvaptan or an analogue. Anuresis or hypernatremia. Patients who have difficulty with fluid intake or can not feel dipsesis. Pregnant woman or possibility of the pregnancy. Patients whom tolvaptan is already given at registration. Patients whom study responsibility physician judged inappropriate.
研究者
相似试验
已完成
不适用
ongitudinal Efficacy and Safety Study of Tolvaptan on Autosomal Dominant Polycystic Kidney Disease PatientsAutosomal Dominant Polycystic Kidney DiseaseJPRN-UMIN000021267Autosomal Dominant Polycystic Kidney Disease Research Section, Kyorin University, School of Medicine119
招募中
不适用
evaluation of Tolvaptan effect for patients after open heart surgeryJPRN-UMIN000017704Department of Cardiovascular Surgery, Tokushima-university40
已完成
4 期
Short term clinical efficacy and safety of Tolvaptan additional treatment compared with escalation treatment of conventional diuretics in HF patients with volume overload despite treatments with the conventional diureticscongestive heart failureJPRN-UMIN000009136Kyoto University Hospital40
已完成
不适用
Comparison of Tolvaptan treatment and conventional treatment in elderly acute heart failure.Acute decompensated heart failureJPRN-UMIN000028039Iiyama redcross hospital60
招募中
不适用
A study to evaluate effect and safety of Tolvaptan in Nephrogenic Diabetes Insipidus caused by mutations in the vasopressin type 2 receptor gene.ephrogenic Diabetes Insipidus caused by mutations in the vasopressin type 2 receptor geneJPRN-UMIN000021708Department of Nephrology and Endocrinology, The University of Tokyo Hospital3